Evaluation of bowel cancer registration data in England, 1996–2004

BACKGROUND: The National Health Service (NHS) bowel cancer screening programme (BCSP) was initiated across England in April 2006. To determine the feasibility of using national cancer registration data to assess the impact of the BCSP on stage-specific incidence, we studied trends in the incidence r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, A M, Morris, E, Thomas, J, Forman, D, Melia, J, Moss, S M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768458/
https://www.ncbi.nlm.nih.gov/pubmed/19773758
http://dx.doi.org/10.1038/sj.bjc.6605321
_version_ 1782173470855004160
author Jones, A M
Morris, E
Thomas, J
Forman, D
Melia, J
Moss, S M
author_facet Jones, A M
Morris, E
Thomas, J
Forman, D
Melia, J
Moss, S M
author_sort Jones, A M
collection PubMed
description BACKGROUND: The National Health Service (NHS) bowel cancer screening programme (BCSP) was initiated across England in April 2006. To determine the feasibility of using national cancer registration data to assess the impact of the BCSP on stage-specific incidence, we studied trends in the incidence rates of colon (ICD10 C18) and rectosigmoid junction and rectum (ICD10 C19–C20) cancers and the completeness of data on Dukes stage in England. METHODS: Data were obtained from all nine cancer registries for the period 1996–2004, before the introduction of the BCSP, in men and women aged 50–79 years. RESULTS: Overall, incidence rates declined by 1% per year in the 9 years before the introduction of the BCSP (P<0.001). Dukes stage was recorded for 60% of all registrations but this varied between regions and over time. Only four registries had completeness of 74% or more. Registrations with unknown Dukes stage decreased from 1996 to 2000, and then increased during 2001–2004 affecting trends in stage-specific incidence. CONCLUSION: To study the impact of the BCSP on stage-specific incidence, regional variations in data completeness need to be addressed.
format Text
id pubmed-2768458
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27684582010-10-20 Evaluation of bowel cancer registration data in England, 1996–2004 Jones, A M Morris, E Thomas, J Forman, D Melia, J Moss, S M Br J Cancer Clinical Study BACKGROUND: The National Health Service (NHS) bowel cancer screening programme (BCSP) was initiated across England in April 2006. To determine the feasibility of using national cancer registration data to assess the impact of the BCSP on stage-specific incidence, we studied trends in the incidence rates of colon (ICD10 C18) and rectosigmoid junction and rectum (ICD10 C19–C20) cancers and the completeness of data on Dukes stage in England. METHODS: Data were obtained from all nine cancer registries for the period 1996–2004, before the introduction of the BCSP, in men and women aged 50–79 years. RESULTS: Overall, incidence rates declined by 1% per year in the 9 years before the introduction of the BCSP (P<0.001). Dukes stage was recorded for 60% of all registrations but this varied between regions and over time. Only four registries had completeness of 74% or more. Registrations with unknown Dukes stage decreased from 1996 to 2000, and then increased during 2001–2004 affecting trends in stage-specific incidence. CONCLUSION: To study the impact of the BCSP on stage-specific incidence, regional variations in data completeness need to be addressed. Nature Publishing Group 2009-10-20 2009-09-22 /pmc/articles/PMC2768458/ /pubmed/19773758 http://dx.doi.org/10.1038/sj.bjc.6605321 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Jones, A M
Morris, E
Thomas, J
Forman, D
Melia, J
Moss, S M
Evaluation of bowel cancer registration data in England, 1996–2004
title Evaluation of bowel cancer registration data in England, 1996–2004
title_full Evaluation of bowel cancer registration data in England, 1996–2004
title_fullStr Evaluation of bowel cancer registration data in England, 1996–2004
title_full_unstemmed Evaluation of bowel cancer registration data in England, 1996–2004
title_short Evaluation of bowel cancer registration data in England, 1996–2004
title_sort evaluation of bowel cancer registration data in england, 1996–2004
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768458/
https://www.ncbi.nlm.nih.gov/pubmed/19773758
http://dx.doi.org/10.1038/sj.bjc.6605321
work_keys_str_mv AT jonesam evaluationofbowelcancerregistrationdatainengland19962004
AT morrise evaluationofbowelcancerregistrationdatainengland19962004
AT thomasj evaluationofbowelcancerregistrationdatainengland19962004
AT formand evaluationofbowelcancerregistrationdatainengland19962004
AT meliaj evaluationofbowelcancerregistrationdatainengland19962004
AT mosssm evaluationofbowelcancerregistrationdatainengland19962004

Ejemplares similares